US Patent 11986515 Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
All edits
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+34 properties)
Article (+293 characters)
US Patent 11986515 Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
Article
Patent abstract
Compositions and methods are described for the delivery of recombinant human iduronate-2-sulfatase (IDS) produced by human neuronal or glial cells to the cerebrospinal fluid of the central nervous system (CNS) of a human subject diagnosed with mucopolysaccharidosis II (MPS II).
Infobox
Is a
Patent Jurisdiction
Patent Number
Patent Inventor Names
Marie-Laure Nevoret0
Paulo Falabella0
Stephen Joseph Pakola0
Date of Patent
May 21, 2024
0Patent Application Number
183569610
Date Filed
July 21, 2023
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11986515 Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
